Current and historical daily PE Ratio for CGNH (
CardioGenics Holdings Inc
) from 2004 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CardioGenics stock (CGNH) PE ratio as of Jun 07 2024 is 0.
More Details
CardioGenics Holdings Inc (CGNH) PE Ratio (TTM) Chart
CardioGenics Holdings Inc (CGNH) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 0
- 1
| CardioGenics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
CardioGenics Holdings Inc (CGNH) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
CardioGenics Holdings Inc
NAICS : 325413
SIC : 2835
ISIN : US14160X2036
Compare
Compare
Traded in other countries / regions
CGNH.USA IPO Date
2004-06-09Description
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers